Quick Answer
Benitec Biopharma Inc. reported Shares Outstanding of 26.25 million shares for fiscal year 2025.
Benitec Biopharma Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 26.25M | +2.8% |
| 2025 | 25.55M | +8.9% |
| 2024 | 23.45M | +132.5% |
| 2024 | 10.09M | +503.4% |
| 2023 | 1.67M | +247.7% |
| 2022 | 480,688 | -94.1% |
| 2021 | 8.17M | +637.3% |
| 2020 | 1.11M | +29.4% |
| 2019 | 856,765 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 34.25M | +46.1% | +30.5% |
| September 30, 2025 | 26.25M | +46.7% | +0.0% |
| June 30, 2025 | 26.25M | +160.3% | +2.8% |
| March 31, 2025 | 25.55M | +837.5% | +8.9% |
| December 31, 2024 | 23.45M | +804.6% | +31.1% |
| September 30, 2024 | 17.89M | +602.4% | +77.4% |
| June 30, 2024 | 10.09M | +503.4% | +270.2% |
| March 31, 2024 | 2.72M | -90.3% | +5.1% |
- Benitec Biopharma Inc. showed an increase of +2.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Benitec Biopharma Inc.’s shares outstanding has grown by 2963.9% (from 856.8 thousand shares to 26.25 million shares).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: